Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Orvain · SciRah

Researcher profile · Semantic Scholar

C. Orvain

Share profile

C. Orvain — researcher profile on SciRah

h-index: 21
Works: 170
Citations: 1,480

Most-cited papers

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
A. de Masson, M. Beylot-Barry, C. Ram-Wolff, J. Mear +49 more
2023The Lancet62 citations Open access
Semantic Scholar
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial
F. Malard, M. Loschi, A. Huynh, T. Cluzeau +28 more
2023EClinicalMedicine55 citations Open access
Semantic Scholar
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study
S. Guillet, V. Loustau, E. Boutin, Anissa Zarour +36 more
2022Blood42 citations Open access
Semantic Scholar
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment
S. Garciaz, P. Dumas, S. Bertoli, D. Sallman +24 more
2024American journal of hematology/oncology21 citations Open access
Semantic Scholar
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
Naveed Ali, M. Othus, E. Rodríguez-Arbolí, C. Orvain +6 more
2024Blood Advances21 citations Open access
Semantic Scholar
Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
E. Rodríguez-Arbolí, M. Othus, C. Orvain, Lucas C Zarling +8 more
2022Haematologica19 citations Open access
Semantic Scholar
Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia – a FILO study
C. Orvain, S. Bertoli, P. Peterlin, Y. Desbrosses +17 more
2024Leukemia18 citations Open access
Semantic Scholar
Relationship Between Donor Source, Pre-Transplant Measurable Residual Disease, and Outcome after Allografting for Adults with Acute Myeloid Leukemia
C. Orvain, Filippo Milano, E. Rodríguez-Arbolí, M. Othus +4 more
2024Leukemia16 citations Open access
Semantic Scholar
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
C. Lacan, Jérôme Lambert, E. Forcade, M. Robin +35 more
2024Journal of Hematology & Oncology15 citations Open access
Semantic Scholar
Acute Myeloid Leukemia Patients Who Stopped Venetoclax or/and Azacytidine for Other Reasons Than Progression Have a Prolonged Treatment Free Remission and Overall Survival. a Filo Study
S. Garciaz, S. Bertoli, D. Sallman, J. Decroocq +14 more
2023Blood13 citations Open access
Semantic Scholar
Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis
Sandrine Lemoine, C. Mornet, I. Quintin-Roué, M. Rousselet +15 more
2022Haematologica13 citations Open access
Semantic Scholar
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis
D. Luque Paz, N. Gagelmann, L. Benajiba, J. Riou +26 more
2024Blood Advances10 citations Open access
Semantic Scholar
Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
E. Rodríguez-Arbolí, C. Orvain, M. Othus, R. Walter
2022Bone Marrow Transplantation10 citations Open access
Semantic Scholar
Impact of Socioeconomic Disparities on Outcome in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Daniel J. Olivieri, M. Othus, C. Orvain, E. Rodríguez-Arbolí +7 more
2024Leukemia9 citations
Semantic Scholar
Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors
E. Rodríguez-Arbolí, M. Othus, C. Orvain, Naveed Ali +7 more
2024Transplantation and Cellular Therapy9 citations Open access
Semantic Scholar
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission – a multi-center study
Christophe Desprez, A. Kouatchet, T. Marchand, J. Mear +19 more
2023Annals of Hematology9 citations
Semantic Scholar
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.
A. de Masson, M. Beylot-Barry, C. Ram-Wolff, J. Mear +46 more
2025Journal of Clinical Oncology8 citations Open access
Semantic Scholar
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study
C. Orvain, S. Chantepie, X. Thomas, M. Escoffre-barbe +34 more
2023Haematologica8 citations Open access
Semantic Scholar
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study
Jules Higué, C. Orvain, P. Dumas, P. Peterlin +24 more
2025Blood Cancer Journal7 citations Open access
Semantic Scholar
Relative Prognostic Value of Flow Cytometric Measurable Residual Disease before Allogeneic Hematopoietic Cell Transplantation for Adults with MDS/AML or AML
C. Orvain, Naveed Ali, M. Othus, E. Rodríguez-Arbolí +6 more
2024American journal of hematology/oncology7 citations Open access
Semantic Scholar
Management of thrombocytopenia and anticoagulant therapy in patients with hematological malignancy on chemotherapy: a binational prospective study (TAT study)
Elie Jalaber, C. Orvain, Vasiliki Papadopoulou, Alexis Genthon +6 more
2025Journal of Thrombosis and Thrombolysis6 citations
Semantic Scholar
Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia
C. Orvain, E. Rodríguez-Arbolí, M. Othus, B. Sandmaier +3 more
2023Cancers6 citations Open access
Semantic Scholar
Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia
Carole Mosnier, Sarah Bellal, L. Cottin, Françoise Boyer +12 more
2025Blood Advances5 citations Open access
Semantic Scholar
Relationship Between Age, Conditioning Intensity, and Outcome After Allografting in Adults Age ≥60 Years with AML
P. Vo, B. Sandmaier, M. Othus, Naveed Ali +6 more
2025Bone Marrow Transplantation5 citations Open access
Semantic Scholar
CALR‐mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
Laure Aubin, R. V. Vilas Boas, Rafael Daltro de Oliveira, Valoris Le Brun +31 more
2024American journal of hematology/oncology5 citations Open access
Semantic Scholar
Relationship Between Age, Conditioning Intensity, and Outcome After Allografting in Adults Age ≥60 Years with AML
P. Vo, Brenda M. Sandmaier, M. Othus, Naveed Ali +6 more
2024Research Square5 citations Open access
Semantic Scholar
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores
Amélie Bachelot, A. Bouvier, J. Riou, S. Thepot +16 more
2023American journal of hematology/oncology5 citations Open access
Semantic Scholar
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia—a Grand Ouest Against Leukemia (GOAL) study
Christophe Desprez, J. Riou, P. Peterlin, T. Marchand +10 more
2022Leukemia5 citations
Semantic Scholar
Outcome of patients with accelerated and blast‐phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination—A FIM study
C. Orvain, S. Tavitian, Clémence Médiavilla, Françoise Boyer +29 more
2025HemaSphere4 citations Open access
Semantic Scholar
A molecular signature predicts hematologic evolution in polycythemia vera patients
Olivier Mansier, Eric Lippert, L. Benajiba, D. Ranta +30 more
2025Leukemia4 citations Open access
Semantic Scholar
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)
S. Bertoli, Emilie Bérard, P. Peterlin, R. Guièze +28 more
2025Haematologica4 citations Open access
Semantic Scholar
Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMC.
H. Johnson-Ansah, A. Charbonnier, Gabriel Etienne, Lydia Roy +17 more
2025Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis3 citations
Semantic Scholar
Impact of early versus conventional kidney replacement therapy initiation in tumor lysis syndrome: a target trial emulation
J. Serre, G. Mulier, Charlotte Boud’hors, M. Lemerle +6 more
2025Annals of Intensive Care3 citations Open access
Semantic Scholar
Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease : Results from Early Access Program in Europe
F. Malard, M. Loschi, T. Cluzeau, Raynier Devillier +33 more
2024Blood3 citations Open access
Semantic Scholar
Molecular Relapse after First-Line Intensive Therapy in Patients with Core-Binding Factor and NPM1-Mutated Acute Myeloid Leukemia - a Filo Study
C. Orvain, S. Bertoli, P. Peterlin, Y. Desbrosses +13 more
2023Blood3 citations Open access
Semantic Scholar
Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study
Maya Belhadj, B. Burroni, O. Kosmider, L. Willems +15 more
2023British Journal of Haematology3 citations
Semantic Scholar
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
M. Balsat, V. Alcazer, G. Étienne, F. Huguet +19 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis3 citations Open access
Semantic Scholar
Progressive multifocal leukoencephalopathy after durvalumab treatment for acute myeloid leukemia: A consequence of an immune reconstitution inflammatory syndrome?
Emeline Vinatier, C. Poli, A. Giltat, Christopher Nunes Gomes +4 more
2022eJHaem3 citations Open access
Semantic Scholar
Induction chemotherapy with a single anthracycline-containing cycle in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups
Christian Récher, C. Pautas, S. Bertoli, P. Dumas +38 more
2025Blood2 citations
Semantic Scholar
Determinants of Isolated CNS Relapse in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia. from Graall-2005 to -2014 Trials
N. Boissel, Emilie Lemasle, S. Chantepie, T. Leguay +26 more
2024Blood2 citations
Semantic Scholar
Outcome of Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms Ineligible for Intensive Chemotherapy or Allogeneic Hematopoietic Cell Transplantation Treated By Azacitidine Alone or in Combination - a FIM Study
C. Orvain, S. Tavitian, Clémence Médiavilla, Françoise Boyer +27 more
2024Blood2 citations
Semantic Scholar
18-Months Follow-up of the Trial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting
F. Nicolini, A. Charbonnier, M. Escoffre-barbe, É. Jourdan +28 more
2024Blood2 citations
Semantic Scholar
Relationship Between Morphologic Remission With or Without Hematologic Recovery and Outcome After Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia
M. Othus, Domitilla Baccon, Naveed Ali, E. Rodríguez-Arbolí +6 more
2024Bone Marrow Transplantation2 citations
Semantic Scholar
Relative Prognostic Value of Flow Cytometric Measurable Residual Disease before Allogeneic Hematopoietic Cell Transplantation for Adults with MDS/AML or AML
C. Orvain, Naveed Ali, M. Othus, E. Rodríguez-Arbolí +5 more
2023Blood2 citations Open access
Semantic Scholar
Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
Arthur Mageau, B. Bonnotte, M. Ebbo, A. Dossier +11 more
2023Platelets2 citations Open access
Semantic Scholar
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria
M. Griffin, D. Eikema, I. Verheggen, Alexander D. Kulagin +20 more
2023Haematologica2 citations Open access
Semantic Scholar
Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma
Agathe Vély, M. Couturier, P. Delépine, R. Le Calloch +12 more
2023Leukemia and Lymphoma2 citations
Semantic Scholar
T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence
F. Nicolini, A. Charbonnier, M. Escoffre-barbe, É. Jourdan +30 more
2023Blood2 citations
Semantic Scholar
Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemia
C. Orvain, M. Othus, Gurleen Johal, M. Hunault-Berger +2 more
2022Leukemia2 citations
Semantic Scholar
CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms
Marine Demoy, Maxence Bauvais, Agathe Vély, Thomas Nicol +11 more
2026Annals of Hematology1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Othus×13
Invite
M. Othus — researcher profile on SciRah
E. Rodríguez-Arbolí×12
Invite
E. Rodríguez-Arbolí — researcher profile on SciRah
M. Hunault-Berger×9
Invite
M. Hunault-Berger — researcher profile on SciRah
J. Ianotto×9
Invite
J. Ianotto — researcher profile on SciRah

×8

Invite

S. Bertoli — researcher profile on SciRah

Invite

P. Peterlin — researcher profile on SciRah

B. Sandmaier×8

Invite

B. Sandmaier — researcher profile on SciRah

A. Charbonnier×7

Invite

A. Charbonnier — researcher profile on SciRah

Invite

A. Huynh — researcher profile on SciRah

Invite

P. Dumas — researcher profile on SciRah

Invite

Naveed Ali — researcher profile on SciRah

Françoise Boyer×7

Invite

Françoise Boyer — researcher profile on SciRah